Cargando…
A Rare Presentation of Zoledronate-Induced Systemic Inflammatory Response
Zoledronic acid is a bisphosphonate commonly used to treat various conditions involving bone loss. While it is generally well-tolerated, the occurrence of severe inflammatory reactions is rare. We present the case of an 82-year-old female who developed a severe immune reaction, including weakness an...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404464/ https://www.ncbi.nlm.nih.gov/pubmed/37551226 http://dx.doi.org/10.7759/cureus.41524 |